An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 7, Issue 284, Pages 284ra57-284ra57
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-04-23
DOI
10.1126/scitranslmed.3010564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and Phenotypic Diversity in Breast Tumor Metastases
- (2014) V. Almendro et al. CANCER RESEARCH
- Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
- (2014) J. J. Tao et al. Science Signaling
- Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
- (2014) Evgeny V. Denisov et al. Scientific Reports
- Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
- (2014) Vanessa Almendro et al. Cell Reports
- Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy
- (2013) D. Habermehl et al. JOURNAL OF RADIATION RESEARCH
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
- (2013) Jeffrey S Ross et al. MODERN PATHOLOGY
- Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
- (2013) Felicitas Merz et al. NEURO-ONCOLOGY
- High-Throughput Methods for Combinatorial Drug Discovery
- (2013) X. Sun et al. Science Translational Medicine
- Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy
- (2013) Changge Fang et al. Journal of Cancer
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- Redefining Clinical Trials: The Age of Personalized Medicine
- (2012) Gayathri Vaidyanathan CELL
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Impact of Genomics on Personalized Cancer Medicine
- (2012) C. L. Arteaga et al. CLINICAL CANCER RESEARCH
- Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?
- (2012) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Overcoming implementation challenges of personalized cancer therapy
- (2012) Funda Meric-Bernstam et al. Nature Reviews Clinical Oncology
- Drug development and clinical trials—the path to an approved cancer drug
- (2012) Eric H. Rubin et al. Nature Reviews Clinical Oncology
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
- (2012) R. Farra et al. Science Translational Medicine
- Multi-Reservoir Bioadhesive Microdevices for Independent Rate-Controlled Delivery of Multiple Drugs
- (2012) Hariharasudhan D. Chirra et al. Small
- Adaptive clinical trials in oncology
- (2011) Donald A. Berry Nature Reviews Clinical Oncology
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
- (2010) S. L. Holbeck et al. MOLECULAR CANCER THERAPEUTICS
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Spending on new drug development
- (2009) Christopher Paul Adams et al. HEALTH ECONOMICS
- Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
- (2008) C.-l. Dai et al. CANCER RESEARCH
- Direct Visualization of Heterogeneous Extravascular Distribution of Trastuzumab in Human Epidermal Growth Factor Receptor Type 2 Overexpressing Xenografts
- (2008) J. H.E. Baker et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More